Home  >  Products  >  FLCN (folliculin ) Blocking Peptide (the C terminal of FLCN)(100ug)
FLCN (folliculin ) Blocking Peptide (the C terminal of FLCN)(100ug)

FLCN (folliculin ) Blocking Peptide (the C terminal of FLCN)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-FLCN Antibody (ARP61521_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61521
Size: 100ug
Weight: 64kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene is located within the Smith-Magenis syndrome region on chromosome 17. Mutations in this gene are associated with Birt-Hogg-Dube syndrome, which is characterized by fibrofolliculomas, renal tumors, lung cysts, and pneumothorax.
Alternative names: BHD; DKFZp547A118; FLCL; FLJ45004; FLJ99377; MGC17998; MGC23445
See Full Product Listings >